Who is the CEO of Anebulo Pharmaceuticals, Inc.?

The CEO of Anebulo Pharmaceuticals, Inc. is Richard Anthony Cunningham.

What industry does Anebulo Pharmaceuticals, Inc. belong to?

Anebulo Pharmaceuticals, Inc. operates in the Biotechnology industry within the Healthcare sector.

Where is Anebulo Pharmaceuticals, Inc. headquartered?

Anebulo Pharmaceuticals, Inc. is headquartered at 1415 Ranch Road 620 South, Lakeway, TX, 78734, US.

What is the IPO date of Anebulo Pharmaceuticals, Inc.?

Anebulo Pharmaceuticals, Inc. went public on May 7, 2021.

How many employees does Anebulo Pharmaceuticals, Inc. have?

Anebulo Pharmaceuticals, Inc. has approximately 2 full-time employees.

Anebulo Pharmaceuticals, Inc.

ANEB•NASDAQ

Healthcare

Biotechnology

$3.19

$-0.05(-1.54%)

Anebulo Pharmaceuticals, Inc. (ANEB) Company Profile & Overview

Explore Anebulo Pharmaceuticals, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Anebulo Pharmaceuticals, Inc. (ANEB) Company Profile & Overview

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.

SectorHealthcare

IndustryBiotechnology

CEORichard Anthony Cunningham

Contact Information

https://www.anebulo.com

512 598 0931

1415 Ranch Road 620 South, Lakeway, TX, 78734

Company Facts

2 Employees

IPO DateMay 7, 2021

CountryUS

Actively Trading

Frequently Asked Questions

;